Long-term outcome of adjuvant chemotherapy with MVP-CAB regimen (Methotrexate, Vincristine, Cisplatin, Cyclophosphamide, Adriamycin and Bleomycin) for locally advanced bladder cancer

UroOncology

Volumn 4, Issue 3-4, 2004, Pages 151-156

  Miyake, Hideaki ^a   Sakai, Iori ^a   Harada, Ken Ichi ^a   Hara, Isao ^b   Eto, Hiroshi ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Adjuvant chemotherapy; Bladder cancer; Multivariate analysis; MVP CAB

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CYSTECTOMY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG TOLERABILITY; DRUG USE; FEMALE; FOLLOW UP; GENDER; HISTOPATHOLOGY; HUMAN; KIDNEY DYSFUNCTION; LEUKOPENIA; LIVER DYSFUNCTION; LONG TERM CARE; LUNG FIBROSIS; LYMPH NODE METASTASIS; MALE; MICROVASCULATURE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 11144244798     PISSN: 15610950     EISSN: None     Source Type: Journal    
DOI: 10.1080/15610950400015174     Document Type: Article

References (18)

1. Gschwend, J.E., Fair, W.R. and Vieweg, J. (2000) "Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies", Eur. Urol. 38, 121-130.
2. Cheng, L., Weaver, A.L., Leibovich, B.C., et al. (2000) "Predicting the survival of bladder carcinoma patients treated with radical cystectomy", Cancer 88, 2326-2332.
3. Wijkstrom, H., Norming, U., Lagerkvist, M., et al. (1998) "Evaluation of clinical staging before cystectomy in transitional cell carcinoma: a long-term follow-up of 276 consecutive patients", Br. J. Urol. 81, 686-691.
4. Stenberg, C.N., Yagoda, A., Scher, H.I., et al. (1985) "Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium", J. Urol. 133, 403-407.
5. Logothetis, C.J., Samuels, M.L., Ogden, S., et al. (1985) "Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases", J. Urol. 134, 460-464.
6. Logothetis, C.J., Johnson, D.E., Chong, C., et al. (1988) "Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update", J. Clin. Oncol. 6, 1590-1596.
7. Skinner, D.G., Daniels, J.R., Russel, C.A., et al. (1991) "The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial", J. Urol. 145, 459-467.
8. Freiha, F., Reese, J. and Torti, F.M. (1996) "A randomized trial of radical cystectomy versus partial cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer", J. Urol. 155, 495-500.
9. Igawa, M., Urakami, S., Shiina, H., et al. (1995) "Long-term results with M-VAC for advanced urothelial cancer: high response rate and low survival in patients with a complete response", Br. J. Urol. 76, 321-324.
10. Miyake, H., Gohji, K., Hara, I., et al. (1999) "Long-term results of neoadjuvant treatment with M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for locally invasive transitional cell carcinoma of the urothelium", Int. J. Clin. Oncol. 4, 32-35.
11. Loehrer, P.J., Sr., Einhorn, L.H., Elson, P.J., et al. (1992) "A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study", J. Clin. Oncol. 10, 1066-1073.
12. Logothetis, C.J., Dexeus, F.H., Finn, L., et al. (1990) "A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors", J. Clin. Oncol. 8, 1050-1055.
13. Gohji, K., Higuchi, A., Maruyama, S., et al. (1993) "Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristin, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report", Jpn J. Clin. Oncol. 23, 291-298.
14. Gohji, K., Ono, Y., Takenaka, A., et al. (1999) "Long-term follow-up results of a pilot phase II study of multidrug chemotherapy (MVP-CAB) in patients with advanced urothelial cancer", Jpn J. Clin. Oncol. 29, 204-208.
15. International Union Against Cancer (1997) TNM Classification of Malignant Tumors (John Wiley & Sons, New York).
16. Mostofi, F.K., Davis, C.J. and Sesterhenn, I.A. (1999) Histological Typing of Urinary Bladder Tumours (Springer Verlag, Berlin).
17. Winquist, E., Kirchner, T.S., Segal, R., et al. (2004) "Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis", J. Urol. 171, 561-569.
18. Millikan, R., Dinney, C., Swanson, D., et al. (2001) "Integrated therapy for locally advanced bladder cancer: final report of a randomized trail of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC", J. Clin. Oncol. 19, 4005-4013.